Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease
欧洲阿尔茨海默病联盟 (EADC) 研究人员就人用药品委员会 (CHMP) 对多纳内单抗用于早期阿尔茨海默病上市许可的否定建议发表评论
期刊:Jpad-Journal of Prevention of Alzheimers Disease
影响因子:7.8
doi:10.1016/j.tjpad.2025.100259
Jessen, Frank; Arbizu, Javier; Boada, Mercé; Balasa, Mircea; Bennys, Karim; Boban, Marina; Bürger, Katharina; Chincarini, Andrea; Cagnin, Annachiara; De Deyn, Peter Paul; Düzel, Emrah; Engelborghs, Sebastiaan; Ewers, Michael; Exalto, Lieza G; van der Flier, Wiesje M; Fortea, Juan; Frederiksen, Kristian Steen; Frisoni, Giovanni B; Frölich, Lutz; Garza-Martinez, Alejandro J; Grimmer, Timo; Hanseeuw, Bernard; Hort, Jakub; Ivanoiu, Adrian; Kehoe, Patrick G; Kennelly, Sean P; Kern, Silke; Klöppel, Stefan; Krajčovičová, Lenka; Kramberger, Milica G; McGuinness, Bernadette; Mecocci, Patrizia; Oberstein, Timo Jan; Ousset, Pierre-Jean; Paquet, Claire; Perneczky, Robert; Piazza, Fabrizio; Plantone, Domenico; Rainero, Innocenzo; Sacco, Guillaume; Salmon, Eric; Santana, Isabel; Scarmeas, Nikolaos; Schneider, Anja; Schott, Jonathan M; Solje, Eino; Stefanova, Elka; Stögmann, Elisabeth; Strauss, Mélanie; Sutovsky, Stanislav; Waldemar, Gunhild; Winblad, Bengt
